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Abstract
Background: Affymetrix GeneChips™ are an important tool in many facets of biological research.
Recently, notable design changes to the chips have been made. In this study, we use publicly
available data from Affymetrix to gauge the performance of three human gene expression arrays:
Human Genome U133 Plus 2.0 (U133), Human Exon 1.0 ST (HuEx) and Human Gene 1.0 ST
(HuGene).
Results: We studied probe-, exon- and gene-level reproducibility of technical and biological
replicates from each of the 3 platforms. The U133 array has larger feature sizes so it is no surprise
that probe-level variances are smaller, however the larger number of probes per gene on the
HuGene array seems to produce gene-level summaries that have similar variances. The gene-level
summaries of the HuEx array are less reproducible than the other two, despite having the largest
average number of probes per gene. Greater than 80% of the content on the HuEx arrays is
expressed at or near background. Biological variation seems to have a smaller effect on U133 data.
Comparing the overlap of differentially expressed genes, we see a high overall concordance among
all 3 platforms, with HuEx and HuGene having greater overlap, as expected given their design. We
performed an analysis of detection rates and area under ROC curves using an experiment made up
of several mixtures of 2 human tissues. Though it appears that the HuEx array has worse
performance in terms of detection rates, all arrays have similar ability to separate differentially
expressed and non-differentially expressed genes.
Conclusion:  Despite noticeable differences in the probe-level reproducibility, gene-level
reproducibility and differential expression detection are quite similar across the three platforms.
The HuEx array, an all-encompassing array, has the flexibility of measuring all known or predicted
exonic content. However, the HuEx array induces poorer reproducibility for genes with fewer
exons. The HuGene measures just the well-annotated genome content and appears to perform
well. The U133 array, though not able to measure across the full length of a transcript, appears to
perform as well as the newer designs on the set of genes common to all 3 platforms.
Background
The use of Affymetrix GeneChips™ is widespread in bio-
medical research for profiling the expression level of thou-
sands of genes simultaneously. The technology has been
well-studied and the data processing algorithms are
mature [1]. For example, Affymetrix maintains a database
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of nearly 10,000 (at the time of writing) scientific articles
using or reviewing their technology [2], and it is arguably
the single most utilized commercial DNA microarray plat-
form.
The trend in genomic data collection has been to interro-
gate more and more biological features (e.g. transcripts,
single nucleotide polymorphisms, proteins). The new
designs from Affymetrix certainly keep to this trend, fol-
lowing advances in design and fabrication that allow
more features on a single chip. Though one may argue
that more is usually better, it is of considerable impor-
tance to ensure that the larger numbers of measurements
can still provide accurate biological insights.
In this study, we compare various measures of perform-
ance of the three most recent human expression arrays:
Human Genome U133 Plus 2.0 (U133), Human Exon 1.0
ST (HuEx) and Human Gene 1.0 ST (HuGene). We use
two publicly available datasets from Affymetrix: an exper-
iment consisting of 3 biological replicates each of 11 tis-
sues and an experiment containing 3 technical replicates
each of 11 RNA mixtures from brain and heart tissue [3].
Each set of RNA has been run on all three platforms. The
focus of our study will be on gene-level summaries,
although we acknowledge that exon arrays have applica-
tions for detecting alternative splice events, as evidenced
by a number of recent publications [4,5].
Affymetrix chip design
Affymetrix chips use 25-mer oligonucleotide probes to
measure the abundance of mRNA transcripts. For the
U133 and previous expression arrays, these probes occur
in pairs, known as perfect match (PM) and mismatch
(MM), where MM probes have a 13th base that does not
match the target sequence and were intended to account
for non-specific binding. Under the standard annotation
provided by Affymetrix, each transcript is interrogated by
11 probe pairs. Many groups prefer to use reassembled
versions of the annotation where sets of probes are geared
toward different databases of genes, transcripts or tran-
script clusters (e.g. Entrez Gene, RefSeq, Unigene) [6].
There are 3 major changes to the design for their new
arrays HuEx and HuGene. First, to allow for more probes
on an array, feature size has been reduced to almost one-
fifth of the area (from 11 by 11 micron squares on U133
to 5 by 5 micron squares on HuEx, HuGene). We investi-
gate the impact of this change on probe-level and gene-
level reproducibility. The second significant design
change is that no matching MM probes are used for every
PM probe. Instead, the HuEx and HuGene arrays have
allocated a small number of MM probes designed to cover
the range of GC content and a number of anti-genomic
probes also covering the range of GC content. Anti-
genomic probes query sequence that is not present in the
human genome nor in other commonly studied model
organisms (mouse, rat, fruitfly, worm, Baker's yeast, Ara-
bidopsis and E. coli). The absence of MM probes has
implications for some summarization algorithms and
also may affect background subtraction procedures. Table
1 of [1] gives a comparative list of normalization, back-
ground subtraction and summarization strategies for
Affymetrix chips, and we refer to the rest of that paper for
a detailed performance comparison. Our processing of the
data is unaffected by the absence of MM probes (see Meth-
ods). Last of all, HuEx and HuGene probes are designed
to interrogate the entire length of a gene, while probes on
the U133 array are mostly at the 3' end of the gene. In the
HuEx and HuGene arrays, probes are designed for each
exon and can be used altogether to summarize the expres-
sion level of a gene. The labeling strategy employed by the
HuEx and HuGene arrays requires sense targets to be
hybridized to the chips.
It is worth mentioning a few more details of content con-
tained on the HuEx and HuGene arrays. HuEx was
designed with probes for virtually all confirmed or puta-
tive exonic content, with the goal of having 4 probes per
probe selection region (PSR). Roughly speaking, a probe
selection region (PSR) is a region that may be, based on all
annotation available, expressed in an independent fash-
ion. In most cases, a PSR is simply an exon. But, there are
many cases where annotation (e.g. EST, gene predictions)
suggests that shorter regions within an exon may need to
be queried separately. In this case, a PSR is created for each
region. The majority of the content on the exon array is
dedicated to "speculative and predictive parts of a gene",
in addition to well-known exons [7]. Though the HuEx
array was not designed as simply an expression array, it
will be used as one and it is important to know how well
it performs as one. The HuGene array is roughly made up
of the subset of the probes to the well-annotated content
on the HuEx array, such as those from the curated and pre-
dicted RefSeq mRNAs. The subset of probes chosen for
HuGene was based on minimizing cross-hybridization,
Table 1: Mixture experiment proportions
Mix 1 Mix 2 Mix 3 Mix 4 Mix 5a, b, c Mix 6 Mix 7 Mix 8 Mix 9
Brain .00 .05 .10 .25 .50 .75 .90 .95 1.00
Heart 1.00 .95 .90 .75 .50 .25 .10 .05 .00BMC Bioinformatics 2007, 8:449 http://www.biomedcentral.com/1471-2105/8/449
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with preference given to probes uniquely matching to the
genome. More details are given later in the paper.
Related work
Exon arrays have been compared to U133 arrays previ-
ously in at least two studies. Gardina et al. [5] highlight
the differences in probe intensity distributions, suggesting
that lower expressed probes see a shift upwards, which is
possibly due to higher sensitivity of the new arrays. Scatter
plots of gene-level summaries of matched probesets show
a reasonable degree of concordance between platforms.
Okoniewski et al. [8] report "high correspondence"
between the HuEx and U133 arrays by comparing techni-
cal replicates of two cell lines on each platform. Using
multiple methods of mapping probesets between the two
platforms, they showed high correlation of fold change
estimates and strong overlap of the common probesets
differentially expressed between the two cell lines. By
applying filters on presence calls (U133) or detection
above background (HuEx), these levels of concordance
are raised.
Thus, despite the major design changes, early evidence
suggests that the HuEx array and U133 array give similar
results, in terms of expression level and fold change esti-
mates. To the best of our knowledge, a comparison of the
HuGene array has only been considered in the Affymetrix
white paper [7].
Description of datasets
We make use of two datasets that are publicly available
from Affymetrix [3]. The first dataset concerns biological
replicates of 11 human tissues: brain, thyroid, breast, pan-
creas, prostate, heart, skeletal muscle, kidney, testis,
spleen and liver. We refer to this throughout the paper as
the tissue experiment. Three biological replicates from a
commercial source were used for each tissue, giving a total
of 33 samples hybridized to each array type. It is not clear
whether exactly the same RNA sample from a replicate on
one platform was used on the other platforms. Even if so,
the samples were separately amplified and labeled. From
an exploratory analysis of gene-level summaries (data not
shown), no obvious correspondences between the repli-
cates across platforms were observed, and this was not the
focus of our analysis. We refer to the second dataset as the
mixture  experiment. In this dataset, commercial total
RNA from brain and heart was mixed together in 9 differ-
ent proportions including both sets of pure samples, as
given in Table 1. The mixture at 50% brain and 50% heart
was repeated 3 times. Each of the 11 mixtures (3 at 50%/
50%) was split into 3 technical replicates, and amplified
and labeled separately, resulting in 33 samples for each
platform. There is no biological variation in the mixture
replicates.
With the changes in array design, it is important to ascer-
tain whether the HuEx and HuGene arrays have a per-
formance similar to that of the U133 arrays. In this paper,
we give a thorough comparison of the three platforms, in
terms of the reproducibility of technical and biological
replicates using both probe-level and gene-level summa-
ries, and of their ability to detect changes in gene expres-
sion. The tissue dataset is used to assess biological
variability. The mixture dataset is used to assess technical
variability, as well as make comparisons in terms of detec-
tion of differential expression. In the absence of a spike-in
experiment where the truth is known, a mixture experi-
ment can be utilized to identify a set of truly changing
genes. To assess performance, we can follow this set of
genes across the range of mixture differences.
Results
Summary of array content
First, it is of interest to get a sense of the number of fea-
tures used to interrogate mRNAs on these array types.
Table 2 summarizes the number of probes and probesets
represented on the 3 platforms, based on either the stand-
ard Affymetrix mapping or an Ensembl-based mapping.
Affymetrix has divided annotation for the HuEx array into
3 non-overlapping groups, in decreasing order of confi-
dence: core (RefSeq and full length mRNAs), extended
(ESTs, sytenic rat and mouse mRNAs) and full (ab-initio
predictions). From Table 2, we see that 80% of the HuEx
array (> 4.1 million probes) is dedicated to the lower con-
fidence content represented by the full and extended sets
of probes. In contrast, the HuGene array represents a sub-
set of the HuEx core set only. Approximately 80% of the
HuGene probes map exactly to HuEx probes. The remain-
ing probes are unique to HuGene but measure exons
already covered in the HuEx core set. Later in the paper,
we make use of probesets organized according to the def-
inition of exons and genes from Ensembl. For this, we
downloaded the U133 probesets from [6] and manually
created probesets for HuEx and HuGene based on genome
coordinates of both the exons and probes. Details of gen-
erating Ensembl-based probesets are in the Methods sec-
tion.
Table 2: Summary of array content
U133 HuEx type HuGene
Number of Probes 
(Affymetrix)
604,258 1,073,146 core 844,550
- 2,001,552 extended -
- 2,152,537 full -
Number of Probesets 
(Affymetrix)
54,675 22,010 core 33,252
Number of Probesets 
(Ensembl-gene)
17,271 28,206 - 27,901
Number of Probesets 
(Ensembl-exon)
- 219,230 - 206,728BMC Bioinformatics 2007, 8:449 http://www.biomedcentral.com/1471-2105/8/449
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Array quality
Many summaries and comparisons discussed later in the
paper could be adversely affected by poorly performing
chips or sets of 3 replicate chips. And, because sets of 3
replicates are reused into various pairwise comparisons,
one poorly performing chip (or set of 3 chips) can affect
many of the comparisons. We first assess the data quality
using standard diagnostic plots [9]. Additional file 1
(pages 1–3) shows relative log expression and normalized
unscaled standard error plots for each of the 3 platforms on
the 33 samples in the mixture dataset.
There is the occasional chip that stands out somewhat
from the rest, but in general not enough to warrant
removal from the analysis. It appears from the quality
assessment plots that more of the HuEx hybridizations
seem to be affected. Because of this, we made a more thor-
ough attempt to investigate the effect of the more poorly
performing chips on our results. A subjective call was
made on the quality of each of the 11 mixtures for each
platform (see Additional file 1, page 4). Later in the paper,
we highlight possible effects that these questionable or
bad chips may have on the analysis.
Probe-level intensity distributions
We begin with the tissue dataset. Because the platforms
have possibly different proportions of highly expressing
content (e.g. due to different numbers of probes per
gene), the 33 tissue samples for each platform are back-
ground adjusted and normalized separately. We have used
an robust multi-chip average (RMA) background subtrac-
tion and then quantile normalization. Full data process-
ing details are given in the Methods section.
Figure 1 presents the probe-level PM intensity distribu-
tions for a single normalized sample from each of the 3
platforms. The intensity distributions for the HuEx array
have been separated into probes corresponding to core,
extended and full probesets. One can see that the probes
from the majority of the full and extended probesets (a
total of 80% of the probes on the array) have intensity
close to background, which is in line with our expecta-
tions. For our purposes, it is not important that the inten-
sity distributions across platforms have slightly different
central values since we do not make direct comparisons at
this level. However, it is interesting to note the distribu-
tions have slightly different shapes. Specifically, a larger
proportion of probes enter into the high end of the inten-
sity scale for the HuEx core and HuGene arrays, suggesting
that querying across the entire length of the gene has
merit.
Reproducibility of technical and biological replicates at 
different levels of summarization
It is of interest to compare the reproducibility of probe-,
exon- and gene-level summaries across platforms. One
way to do this is to calculate variances for each probe, with
lower variances suggesting greater reproducibility. We cal-
culate the mean intensity for each set of 3 replicates, and
the 11 variances, each on 2 degrees of freedom (since
there are 11 tissues and 11 mixtures), thus accounting for
different intensity levels across tissues/mixtures. These
residual variances are then averaged over the 11 estimates
to arrive at a single variance for each probe, for each plat-
form, having 22 degrees of freedom. Figure 2 summarizes
the distribution of pooled probe-level variances for both
experiments across the 3 platforms, with the HuEx probes
split into the 3 levels of annotation. We have examined
the homogeneity of the variances for each probe across
mixture/tissues proportions, and only a very small pro-
portion are non-homogeneous (data not shown).
There are a number of interesting observations that can be
made on the basis of these displays. We know that the
U133 feature sizes are nearly 5 (112/52) times larger than
those on the other platforms. According to the medians of
the probe-level variance distributions for the technical
replicates, the U133 array has 2.1 and 2.2 times lower var-
iance than the HuEx core probes and HuGene probes,
respectively. HuEx's extended and full probes have higher
variances, as would be expected, since a larger proportion
of them are near background. A very similar mean-vari-
ance relationship is observed across platforms (see Addi-
tional file 1, page 5), though shifted in the variance, as
observed in the boxplots of Figure 2. Since the tissue
experiment uses biological replicates and the mixture
experiment uses technical replicates, it is not surprising
that the variances are lower for the mixture experiment.
However, it is not clear why biological variation contrib-
utes quite a bit less to the U133 platform than to the
whole-transcript-based platforms. It is possible that the
new labeling strategy contributes to this, since HuEx and
HuGene are similarly affected. It is also possible that the
samples were processed at different times or handled dif-
ferently. To assess the effect of background adjustment
and normalization on the HuEx array, we processed the
data for the HuEx core probes in two different ways: one
including all probes, and one treating the array as if it were
made up of core probes only. This had very little effect on
the intensity or variance distributions (data not shown),
so the fact that the HuEx array contains 80% of probes
near background is inconsequential to probe level sum-
maries.
Next, we compare variances at different summarization
levels. The RMA model can work with probesets that are
exons or probesets that encompass all the probes for aBMC Bioinformatics 2007, 8:449 http://www.biomedcentral.com/1471-2105/8/449
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Probe intensity distributions Figure 1
Probe intensity distributions. Probe-level intensity distribution of a single normalized (RMA-background corrected and 
quantile normalized) sample for each of the 3 platforms. For the HuEx array, the distribution are split into the core (solid line), 
extended (dashed line) and full (dotted line) probes. The extended and full probe intensity distributions are practically indistin-
guishable.BMC Bioinformatics 2007, 8:449 http://www.biomedcentral.com/1471-2105/8/449
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given gene. Gene-level summaries should be less variable
than exon-level summaries, which in turn should be less
variable than probe-level intensities. As before, we average
variances across the 11 sets of replicates for either the
exon-level or the gene-level summaries, for both experi-
ments. Using custom created probesets based on Ensembl
annotation (see Methods), we can compare exon-level
summaries (for the HuEx and HuGene arrays) as well as
gene-level summaries. The numbers of probes per gene or
exon and the median probe- and gene-level variances for
technical replicates are summarized in Table 3. Figure 3
illustrates the variances at different summarization levels
across platforms for both experiments using Ensembl-
based probesets. Each boxplot shows the variance distri-
bution (on the log scale) over all probes or (Ensembl-
based) probesets for the corresponding platform, accord-
ing to Table 3. Interestingly, constitutive exons (see Meth-
ods) have a variance distribution that is effectively
identical to that of the non-constitutive exons (data not
shown). At both the probe- and gene-level, the U133 array
has the best reproducibility. Due to the larger number of
probes per gene, the gene-level reproducibility on the
HuGene array is effectively the same as U133. It appears
that more probes per gene on the HuEx array is not effec-
tive in reducing the variance to the desired extent. The
median probe-level variances are essentially the same on
the HuEx (core) and HuGene platforms, however, the
gene-level median variance is 1.8 times higher on the
HuEx array compared to HuGene, despite having more
probes per gene. It appears that is this largely due to the
distribution of number of probes per gene for Ensembl-
based probesets. Generally, more probes for a gene leads
to greater reproducibility (see Additional file 1, page 6).
However, the HuEx and HuGene platforms differ drasti-
cally in the distribution of number of probes per gene (see
Additional file 1, page 7). The HuEx array is designed for
exon coverage, so longer genes always have more probes.
The HuGene array is designed to have most probesets with
the average number of probes per gene (~26), regardless
of the length of the gene. In fact, there are several thou-
sand "single-exon" genes (according to Ensembl) that
have only 4 probes on the HuEx platform but more than
10 on the HuGene platform (see Additional file 1, pages
8–9). These differences in the probe selection for the
HuEx and HuGene arrays largely account for the shift in
gene-level variances.
Figure 3 also highlights the possibility of using the
HuGene array as an exon array for well-annotated con-
tent. The HuGene platform has probes designed across the
full length of a transcript. The median exon-level variance
is only 1.4 times larger, despite the smaller number of
probes. In addition, HuGene probes cover ~95% of the
Probe-level reproducibility Figure 2
Probe-level reproducibility. Boxplots of the distribution of pooled variances across probes for each of the 3 platforms for 
the technical replicates of the mixture experiments (white) and the biological replicates of the tissues experiment (grey). The 
HuEx probes are split into core, extended and full.BMC Bioinformatics 2007, 8:449 http://www.biomedcentral.com/1471-2105/8/449
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exons covered in full HuEx array, according to Ensembl
annotation.
From Figure 3, it again appears that the contribution of
biological variability in the tissue experiment represents
different proportions of the total variability at the gene-
level across the platforms. The U133 array appears to pro-
pogate a smaller amount of biological variability, whereas
there is a larger difference between technical and biologi-
cal variances from the HuEx and HuGene arrays. It is pos-
sible that some artifact in the sample handling or
biological samples has introduced a higher level of noise,
or it could be that there is truly more biological variability
that the newer platforms are now measuring.
Finding differentially expressed genes
For the rest of the paper, we focus on the mixture dataset.
To allow for an easier matching of probesets between plat-
forms, we employ the Ensembl gene-centric probesets dis-
cussed in the previous section. We restrict our comparison
to the same 16,941 Ensembl genes (the intersection of the
3 sets of Ensembl identifiers) measured by all three plat-
forms. This number is slightly larger than the 15,585
matched probesets used in the Affymetrix white paper [7].
A scatter plot of the averaged gene-level summaries for
one particular mixture is given in Additional file 1 (page
10), highlighting the concordance between platforms. We
observe a correlation of 0.80 between U133 and either of
HuEx and HuGene despite a somewhat non-linear rela-
tionship. The non-linearity in gene-level summaries is
partly due to observing genes with slightly higher intensi-
ties on HuEx and HuGene arrays, as noted previously by
[5], suggesting a higher sensitivity for the new platforms.
The correlation between HuEx and HuGene is high at
0.98, as expected given they are designed similarly and in
fact they share a large number of probes.
Next, we consider the task of finding differentially
expressed (DE) genes between the brain and heart sam-
ples using the mixture experiment. Using the common set
of Ensembl genes, we computed moderated t-statistics
using limma [10] for the changes between the 3 pure brain
(Mix 9) and 3 pure heart (Mix 1) samples. Figure 4 shows
the number of genes that overlap, based on the top 2,000
moderated t-statistics from each platform. Because of the
differences in array design, it is inevitable that the U133
Table 3: Summary of probe- and gene-level variances for 
technical replicates
U133 HuEx HuGene
Average Number of Probes per Gene 16.1 44.8 26.8
Average Number of Probes per Exon - 5.8 3.7
Median Probe-Level Variance 0.139 0.306 0.308
Median Exon-Level Variance - 0.086 0.119
Median Gene-Level Variance 0.015 0.035 0.020
Probeset-level reproducibility Figure 3
Probeset-level reproducibility. Boxplots of the distribution of pooled variances for probe-, exon- (HuEx and HuGene only) 
and gene-level summaries for each of the 3 platforms for the technical replicates of the mixture experiments (white) and the 
biological replicates of the tissues experiment (grey). Probesets are based on Ensembl genes.BMC Bioinformatics 2007, 8:449 http://www.biomedcentral.com/1471-2105/8/449
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chips will measure slightly different effects, whereas the
HuEx and HuGene should generally measure the same
transcripts. Despite this, the intersection of all 3 array
types contains nearly 65% of each platform's DE genes.
U133 has 25% uniquely represented DE genes whereas
the DE genes from the HuEx and HuGene arrays overlap
by ~80%, as expected. In comparing the top ranked 1,000
and 3,000 moderated t-statistics for each platform, the
percent overlap results are very similar (data not shown).
In the next section, we follow a set of DE genes across all
the mixtures as a means to assess performance. Before
doing this, it is interesting to compare the number of
genes deemed differentially expressed (DE), given that by
restricting to the same set of genes, each platform will
have the same penalty for multiple testing. We used the
moderated t-statistics from limma [10] to compute raw p-
values, which are then adjusted by a Benjamini-Hochberg
correction. Table 4 summarizes the number of genes at
different estimated false discovery rates. Here, we see first
of all that there are a large number of DE genes (~50% of
the common set), giving a large pool for us to assess per-
formance with and that, by using the same false discovery
rate (FDR) cutoff, HuGene consistently calls the largest
number of genes and HuEx calls the smallest. The reason
for the difference is due in part to the inner workings of
limma. Specifically, a higher estimated prior degrees of
freedom, which results when the variances are more uni-
form (i.e. genes have approximately the same variance),
can lead to more genes called as DE, since the threshold
on the absolute t-statistics at a given FDR, everything else
equal, is lower. For the pure brain-pure heart comparison
(Mix 1-Mix 9), the residual variances on the HuGene plat-
form are most uniform, allowing more genes to be called
DE at a preset FDR threshold. The higher uniformity of
variances for the HuGene platform is presumably due to
the very uniform number of probes per gene. To test
whether HuGene data consistently had more uniform var-
Table 4: Numbers of differentially expressed genes
U133 HuEx HuGene
FDR = .05 10,991 10,183 11,252
FDR = .01 9,359 8,474 9,764
FDR = .001 7,416 6,694 8,181
Overlap of top 2,000 differentially expressed genes Figure 4
Overlap of top 2,000 differentially expressed genes. Venn Diagram showing the overlap of top moderated t-statistics 
between pure brain and pure heart samples using Ensembl mappings.BMC Bioinformatics 2007, 8:449 http://www.biomedcentral.com/1471-2105/8/449
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iances, we compared the estimated prior degrees of free-
dom across the set of 36 possible pairwise mixture
comparisons (not including Mix 1 and Mix 9). The esti-
mated prior degrees of freedom was consistently higher
for comparisons on the HuGene array, as shown in Addi-
tional file 1 (page 11). If gene-level variances are consist-
ently more uniform in many HuGene datasets, that could
prove advantageous for the platform in many applica-
tions.
Detection rates
For our analysis of detection rates, we fix the set of DE
genes according to the comparison between pure brain
and heart samples and follow these genes across several
other comparisons. In order to not bias towards a particu-
lar platform, we select 3 sets of DE genes, one for each
platform separately and follow each set across all the RNA
mixtures for the corresponding platform. To make the
comparisons fair, we make pairwise comparisons between
all sets of 3 samples (after setting aside the pure brain and
pure heart sets). Each comparison is thus made up of total
of 6 samples: 3 technical replicates of one mixture condi-
tion against 3 technical replicates of another mixture con-
dition. Since there are 9 mixture levels (Mix 2 to Mix 8,
with Mix 5 repeated 3 times), we have 36 possible pair-
wise comparisons, independent of the 2 sets of pure mix-
tures (Mix 1 and Mix 9). Our strategy is similar to the
approach used by Affymetrix in their white paper [7],
except that they selected genes using all mixtures. We have
selected our set of "true" DE genes independently of the
dataset used to evaluate performance.
For our purposes, detection is defined as the ability to call
a truly DE gene, here predefined independently, as DE for
a given comparison. We compare the ability to detect gene
expression changes by following our sets of truly DE genes
across mixtures where the degree of difference can be
small.
An asymmetry is introduced when considering expression
summaries on the log scale. We have found it important
to summarize the results in terms of the difficulty of the
problem. Figure 5 illustrates a hypothetical truly DE gene
that is highly expressed in heart tissue and lowly expressed
in brain tissue and, assuming linearity, the noiseless pro-
file that should be observed in our processing of the data
(log-scale). Shown on the plot are the mixtures at 5% (Mix
2) and 25% (Mix 4) brain and at 75% (Mix 6) and 95%
(Mix 8) brain. Making comparisons of the Mix 2 and Mix
4 samples (a 20% difference) and the Mix 6 and Mix 8
samples (also a 20% difference) are very different for this
particular gene, in terms of the difficulty of finding differ-
ential expression. While it may be easy to detect this dif-
ference in Mix 6-Mix 8 comparison (here, a difference of
>2 on the log-scale), it may be very difficult to detect this
difference in the Mix 2-Mix 4 comparison (here, a differ-
ence of <0.5). So, we split the 36 possible comparisons
into easy and hard, based on two sets of genes (i.e.
whether the curve ascends or descends) and whether it is
the first half or second half of the curve (from Figure 5).
Some easy comparisons are not considered since they are
so large that they do not distinguish the platforms. Figure
6 shows MA plots to highlight the asymmetry in another
way for the Mix 2-Mix 4 comparison and the Mix 6-Mix 8
comparison, both 20% differences, with sets of brain and
heart genes highlighted. A discussion of how these genes
were selected is given below. It is quite evident that the
difficulty of finding differential expression between two
mixture samples of the same difference (here, 20%) is
dependent on the direction of the change and the initial
expression level. Table 5 gives the comparisons that we are
considering and how they are stratified into easy and
hard. Note that the difficulty in detecting expression
changes is not solved by using the linear scale. The reason
for using the log scale is to make the assumption of com-
mon variance (as used in limma, for example) more real-
istic. Typically, variances increase with intensity and
detecting a 20% difference at high expression values
would remain difficult on the linear scale.
In our first analysis, we compare detection rates across
platforms. Since each platform has a large number of total
DE genes, we followed the top 4,000 genes (according to
adjusted p-value) across the pairwise comparisons of
interest. Detection rate for a given mixture comparison is
defined as the proportion of the initial set of 4,000 true
DE genes that are below a preset cutoff. Therefore, detec-
tion rate is another term for recall or sensitivity. In our
case, one might call it apparent sensitivity, since we use
data to determine our set of true DE genes to start with.
In this analysis, we used a 5% FDR threshold for all com-
parisons, based on the adjusted p-values. We have only
considered comparisons where the mixture difference is
smaller than 50% since the larger differences do not sepa-
rate the platforms. Figure 7 shows detection rates as a
function of the difference in mixtures for the top 4,000
genes, split by brain and heart genes, and into easy and
hard detection problems for these genes. In general, as the
degree to which two mixtures are different increases, more
of the true DE genes are detected as changed. Of the 4000
genes for each platform, 1,885, 1,782 and 1,936 genes,
respectively for the U133, HuEx and HuGene arrays are
designated as "brain" genes. The sets of genes we consider
here are different for each platform, though they largely
overlap, as noticed previously. Though it is not particu-
larly evident from Figure 7 that the "easy" detection prob-
lems always give higher detection rates, it is quite clear
when you consider fewer top genes. Detection rates for the
top 1,000 and 2,000 genes are shown in Additional file 1BMC Bioinformatics 2007, 8:449 http://www.biomedcentral.com/1471-2105/8/449
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(pages 12–13). The major trends are conserved with an
increase in the overall detection rates. Also in the Supple-
mentary materials, we made an attempt to highlight com-
parisons that may contain one or more chips of lower
quality. It appears that some but not all of comparisons
with unexpectedly low detection rates observed can be
attributed to array quality.
In terms of detection rates, U133 and HuGene have the
best overall performance, where each are top-ranked in 2
of 4 comparisons and second-ranked in the other 2 com-
parisons. With smaller sets of genes, U133 appears to be
marginally better.
ROC analysis
Next, we consider a very similar analysis to detection rates
except we form a "matching" set of deemed non-DE
genes. Under this framework, we can generate a receiver
operating characteristic (ROC) curve for each comparison
based on separating the DE (positives) and non-DE (neg-
atives) genes, thereby not relying on a particular cutoff.
We start with the same 4,000 truly DE genes from the pre-
vious section. Typically, the DE genes are biased towards
higher expression, so we pick a set of non-DE genes that
are matched in intensity (here, intensity is defined as the
average log-expression over the 6 pure samples). From the
comparisons of pure samples (Mix 1-Mix 9), we ranked
genes according to adjusted p-values. The top 4,000 make
up the true DE set, as before. From the lowest 8,000 genes
Illustration of asymmetry for a hypothetical gene Figure 5
Illustration of asymmetry for a hypothetical gene. A hypothetical gene that is differentially expressed between heart and 
brain (highly expressed in heart). Y-axis gives the expression level on the log-scale. X-axis is the proportion of brain RNA mak-
ing up the mixture (heart RNA makes up the remainder). Highlighted with the dotted lines are the mixtures with 5%, 25%, 75% 
and 95%, showing that finding differences between 5% and 25% (a 20% difference) and 75% and 95% (also a 20% difference) 
have very different degrees of difficulty.BMC Bioinformatics 2007, 8:449 http://www.biomedcentral.com/1471-2105/8/449
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(i.e. genes designated as non-DE), we devised an approxi-
mate weighted sampling scheme (with weights based on
the DE and non-DE intensity distributions) to select the
4,000 non-DE genes. Details of the weighted sampling are
given in the Methods section. We then follow the set of
8,000 genes (4,000 DE, 4,000 non-DE), chosen separately
for each platform, across the comparisons of interest.
We consider the problem of separating the positives and
negatives, preset from the Mix 1-Mix 9 comparison, across
each pairwise mixture comparison of interest. This ulti-
mately leads to an ROC curve for each comparison. Since
we have several comparisons, we wish to summarize each
ROC curve with a single value. One common way to sum-
marize ROC curves is the area under the curve (AUC). In
practice, we are typically not tolerant of false positive (FP)
rates beyond 10%, so we have summarized each ROC
curve with a partial area, the area up to a FP rate of 10%
and scale each area to have a value between 0 and 1 [11].
Figure 8 gives partial areas (pAUCs) for the same stratifi-
cation of genes (heart/brain) and comparisons (easy/
hard) as in the previous section (Table 5). Overall, these
comparisons show that, again, as the degree to which two
Table 5: Difficulty of pairwise mixture comparisons
MD Heart Genes MD Brain Genes
Easy Comparisons .05 Mix 7-Mix 8 .05 Mix 2-Mix 3
.15 Mix 6-Mix 7 .15 Mix 3-Mix 4
.20 Mix 6-Mix 8 .20 Mix 2-Mix 4
.25 Mix 5-Mix 6 .25 Mix 4-Mix 5
.40 Mix 5-Mix 7 .40 Mix 3-Mix 5
.45 Mix 5-Mix 8 .45 Mix 2-Mix 5
Hard Comparisons .05 Mix 2-Mix 3 .05 Mix 7-Mix 8
.15 Mix 3-Mix 4 .15 Mix 6-Mix 7
.20 Mix 2-Mix 4 .20 Mix 6-Mix 8
.25 Mix 4-Mix 5 .25 Mix 5-Mix 6
.40 Mix 3-Mix 5 .40 Mix 5-Mix 7
.45 Mix 2-Mix 5 .45 Mix 5-Mix 8
Comparisons Not 
Considered
.50 Mix 4-Mix 6 same as heart genes
.65 Mix 3-Mix 6
.65 Mix 4-Mix 7
.70 Mix 2-Mix 6
.70 Mix 4-Mix 8
.80 Mix 3-Mix 7
.85 Mix 2-Mix 7
.85 Mix 3-Mix 8
.90 Mix 2-Mix 8
MA plots for different 20% mixtures Figure 6
MA plots for different 20% mixtures. M (log-fold change) versus A (intensity) for two 20% mixture difference compari-
sons: Mix 6-Mix 8 and Mix 2-Mix 4. Shown here is the HuEx data only. Genes expressed significantly higher in the pure heart 
samples (2,218) are shown in red and brain-expressed genes (1,782) are shown in green. In terms of the difficulty in detecting 
differential expression, the two 20% mixtures are very different.BMC Bioinformatics 2007, 8:449 http://www.biomedcentral.com/1471-2105/8/449
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mixtures are different increases, the truly DE genes and the
non-DE genes are more easily separated. Additionally,
these comparisons reveal that the platforms perform more
similarly than suggested by detection rates. This is partly
due to the different behaviour of the non-DE genes for
some comparisons (see Additional file 1, page 14).
Despite these differences, it appears that the platforms
have very similar performance in terms of separating pre-
defined sets of DE and non-DE genes, with U133 having
a slight advantage. pAUCs for the top 1,000 and 2,000 DE
genes (with corresponding matched sets of non-DE genes)
Detection rates Figure 7
Detection rates. Detection Rates (proportion of previously selected "true" genes for each platform that are below the set 
FDR cutoff) stratified by brain and heart and "easy" and "hard" detection problems. X-axis is the mixture difference of the com-
parison. Y-axis gives the detection rate.BMC Bioinformatics 2007, 8:449 http://www.biomedcentral.com/1471-2105/8/449
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are given in Additional file 1 (pages 15–16), again show-
ing very similar results.
Conclusion and Discussion
We made a thorough performance comparison of the
three most recent human gene expression chips available
from Affymetrix: Human Genome U133 Plus 2.0, Human
Exon 1.0 ST and Human Gene 1.0 ST. First, we have com-
pared reproducibility at the probe-, exon- (where possi-
ble) and gene-level using publicly available data on
technical and biological replicates. We then focussed on
gene-level performance, which included the overlap of DE
ROC analysis Figure 8
ROC analysis. Partial AUCs (area under the ROC curve up to FP = 10%, normalized to have a maximum possible value of 1) 
stratified by brain and heart and "easy" and "hard" detection problems. X-axis is the mixture difference of the comparison. Y-
axis gives the pAUC.BMC Bioinformatics 2007, 8:449 http://www.biomedcentral.com/1471-2105/8/449
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genes from a set of RNA samples that were run on all 3
platforms.
Summarization (gene- or exon-level) relies on pre-defined
probesets. The question of how and what probes are
organized into a probeset is a complex one. One previ-
ously proposed strategy for the HuEx array removed
probes entirely, employing a hierarchical clustering
approach to select only those probes that agree to some
extent with the rest [12]. The robust fit of the RMA model
will account for this smoothly by downweighting probes
that disagree with the majority. Another strategy, in light
of the probe- to gene-level improvement of the HuGene
array, and the fact that the HuGene probes are largely a
subset of the HuEx probes, is to use that subset of probes
where possible for the HuEx array. However, this is not
always possible since the HuGene has a collection of
probes unique to the platform. Another approach is to use
constitutive exons only in gene-level summaries, but it
does not appear that these are measured with any higher
precision. Many of the exons from our Ensembl mapping
include 2 or more probe selection regions from Affyme-
trix. These effects are important and are worthy of further
study, but are beyond the scope of our study, as we aimed
to make general comparisons based on standard process-
ing.
Probe-level reproducibility, both on technical and biolog-
ical replicates, is better on the U133 array doubtless due
to the larger feature size. Based on probesets organized to
target the Ensembl gene collection, the HuGene array
makes effective use of its ~27 probes per gene to give gene-
level reproducibility quite close to that of the U133 array.
There are major differences in the distribution of number
of probes per gene between the HuEx and HuGene arrays,
which contributes to the different levels of reproducibility
at the gene level. Because the HuEx is designed for exon
coverage, the number of probes per gene increases with
the number probe selection regions for that gene. In the
HuGene array, the number of probes is designed to be
more uniform, regardless of the number of exons. As a
result, there are a few thousand single-exon genes (in the
Ensembl gene catalogue) that are represented by a near-
average number of probes on the HuGene array, but only
4 probes on the HuEx array, which affects the distribution
of gene-level variances.
Like HuEx, HuGene is designed to measure expression
over the full length of a transcript. Consequently, there is
the possibility that HuGene array could itself be used as
an economical exon array for just the well-annotated con-
tent. Its exon-level reproducibility is not much worse than
the full HuEx array and the coverage of human exons is
high. Clearly, further study would be required to deter-
mine whether HuGene could detect alternative splice
events reliably. The main advantage of the HuEx array is
its ability to measure practically every known or predicted
exonic sequence in the genome.
It appears that the additional variance of biological repli-
cates over technical replicates is smaller on the U133 plat-
form. This may be due to the different labeling strategy on
the HuEx and HuGene arrays, but a more directed experi-
ment would be required to verify this. Another explana-
tion is that HuEx and HuGene are more sensitive and
simply uncover more true biological variability.
In overlapping DE genes across platforms for the same
dataset, a high concordance is observed, as noted previ-
ously [8]. Because of the similar design, the DE genes
overlap at a higher rate between the HuEx and HuGene
arrays, than either with the U133 array, even when using
Ensembl-centric summaries. For a given FDR using limma,
the HuGene array calls the most DE genes between the
pure heart and pure brain samples. This is due largely to
the fact that estimated residual variances are more similar
and more sharing between genes is done by the empirical
Bayes model.
Lastly, we compared platforms in terms of detecting
expression changes and the ability to separate pre-defined
sets of truly changing and non-changing genes. In present-
ing our results, we highlighted the asymmetry introduced
by adopting the log scale. While it appears that U133 and
HuGene show some slight advantage based on detection
rates, the pAUC performances of all 3 platforms are very
similar. In summary, the extra probes on the HuEx and
HuGene array seem to regain most of the performance
lost from having smaller individual features. Processing
the HuEx data into gene-level summaries may benefit
from judicious probe selection. All platforms have similar
performance in distinguishing between DE and non-DE
genes according to a mixture experiment.
Methods
Datasets
The tissue and mixture datasets are available from [3].
Some additional descriptions of the experiments can be
found from the Affymetrix website as well as within the
white paper [7].
Data processing
For all the gene- or exon-level summaries, we process the
data using the linear model from RMA, but fit robustly
using probe level models [13] instead of median polish.
We use the R package aroma.affymetrix [14], which allows
essentially unlimited numbers of large Affymetrix datasets
to be analyzed using persistent memory.BMC Bioinformatics 2007, 8:449 http://www.biomedcentral.com/1471-2105/8/449
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Probe level models are fit to RMA-background corrected
and quantile normalized data to get gene-level (or exon-
level) summaries. Affymetrix makes unsupported CDF
files available for U133 and HuGene chips. The initial
CDF file for HuEx was created from the 'mps' annotation
that can be downloaded from the Affymetrix downloads
page [15].
Creation of ensembl-centric probesets
Version 9 of the Ensembl-centric CDF files were used for
U133 [16]. Using Biomart [17], tables of gene and exon
identifiers with corresponding genome coordinates were
downloaded to a file. Genome coordinates for each of the
HuEx and HuGene probes are given in the ".probe.tab"
files available from Affymetrix. To associate probes with
exons, we compared genome coordinates, requiring a
probe to be fully within an exon to be kept.
The gene to exon to probe CDFs were created in a nested
way such that they can be used within 'ExonRmaPlm'
objects in the aroma.affymetrix package. See [14] for more
details. This allowed us to easily create exon-level summa-
ries using the mergeGroups = F tag or gene-level summa-
ries using the mergeGroups = T tag.
The custom made Ensembl-based CDFs can be down-
loaded from [18].
Weighted sampling
In order to match the set of non-DE genes in intensity to
the DE genes, we adopted an approximate weighted sam-
pling procedure. First, smoothed densities of the intensi-
ties of the 4,000 DE genes and the 8,000 non-DE genes
were calculated for the same grid of points using the den-
sity function in R. For each gene in the non-DE set, a
weight was given according to the ratio of densities (DE to
non-DE) as a function of intensity. 4,000 genes were
selected from the 8,000 according to these weights, giving
a sample that has approximately the same intensity distri-
bution.
Constitutive exons
When downloading the full list of human exons from
BioMart, a column was selected to indicate whether an
exon was considered constitutive or not. According to the
BioMart documentation, this is determined simply based
on whether or not an exon is present in all transcripts for
a given gene. Approximately 52% of the exons in the
human database are constitutive.
Data analysis
All data analysis was performed in R [19]. The quality
assessment plots (see Additional file 1, pages 1–3) are cre-
ated using functions from the affyPLM package. The plots
in Additional file 1, page 5, are created using the smooth-
Scatter function of the geneplotter R package. The pooled
variances are calculated as:
where   is the sample variance for the nkobservations in
each sample set k. In this study, nk = 3 for all k, so the
pooled variance is simply the arithmetic average of all
residual variances. K = 11 for both the tissue and mixture
experiment. See the "Two Groups: Affymetrix" section of
the limma user's guide for a description of a comparisons
of 2 sets of samples, as used for all comparisons in the
detection rate and pAUC analyses. ROC curves were calcu-
lated using the ROCR package.
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